COVID-19 test kit 96/480T

for neutralizing antibodySARS-COV-2clinical

Product Description
2019-nCoV Neutralization Antibody Test Kit (ELISA) is an assay for qualitative detection or semiquantitative estimation of neutralizing antibodies against 2019-nCoV using an enzyme-linked immunosorbent assay format. The kit is intended for in vitro diagnostic use to support serological evaluation of neutralizing antibody presence.

Product Features

• High sensitivity: 98.61%
• High specificity: 99.11%
• Rapid results suitable for laboratory workflows

Method
Enzyme-linked Immunosorbent Assay (ELISA).

Result Interpretation
• The negative/positive cutoff value for 2019-nCoV neutralizing antibody is determined by the inhibition rate. Inhibition rate = (1 - sample OD value / negative quality control OD value) × 100%
• Inhibition rate ≥ 20% is positive (neutralizing antibody detected);
• Inhibition rate < 20% is negative (neutralizing antibody not detected).

Characteristics / Technical specifications

• Sensitivity: 98.61%
• Specificity: 99.11%
• Method: Enzyme-linked Immunosorbent Assay (ELISA)
• Result cutoff: Inhibition rate ≥ 20% = positive; Inhibition rate < 20% = negative